Inhibitors targeting upstream PKC and PI3K signaling to induce apoptosis in cancer cells through reducing phosphorylation of 4E-BP1 leads to inhibition of eIF4E and eIF4F activity [14,15]. Here, EIF4EBP1 is linked to cancer.